Does Tranexamic Acid Reduce Bleeding during Femoral Fracture Operation?

Authors

  • Abbas Sedighinejad Anesthesiology Research Center, Guilan University of Medical Sciences (GUMS), Poursina hospital, Rasht, Iran
  • Ahmadreza Mirbolook Guilan University of Medical Sciences (GUMS), Orthopedic Research Center, Poursina hospital, Rasht, Iran
  • Bahram Naderi Nabi Guilan University of Medical Sciences (GUMS) Anesthesiology, Research Center, Poursina hospital, Rasht, Iran
  • Gita KHanjanian Anesthesiology Research Center, Guilan University of Medical Sciences (GUMS), Poursina hospital, Rasht, Iran
  • Hossein Ettehad Guilan University of Medical Sciences (GUMS), Orthopedic Research Center, Poursina hospital, Rasht, Iran
  • Mohammad Haghighi Anesthesiology Research Center, Guilan University of Medical Sciences (GUMS), Poursina hospital, Rasht, Iran
  • Mohsen Mardani-kivi Guilan University of Medical Sciences (GUMS), Orthopedic Research Center, Poursina hospital, Rasht, Iran
Abstract:

Background:Proximal Femoral shaft fractures are commonly associated with marked blood loss which can lead topostoperative acute anemia and some other complications.Tranexamic acid (TA) is an antifibrinolytic medication that reduces intra-and postoperative blood loss and transfusionrequirements during some elective surgeries (1-3).The aim of this study is to evaluate the effect of intravenous Tranexamic acid (TA) on intraoperative blood loss and asubsequent need for transfusion in patients who were undergoing surgery for femoral shaft fractures in trauma setting.Methods:Thirty-eight ASA grade I-II patients undergoing proximal femoral shaft fracture surgery with intra medullarynailing were included in this double blind randomized controlled clinical trial. They were allocated into two groups. GroupI, the intervention group with eighteen patients received 15 mg/kg (TA) via intravenous infusion before surgical incision.Patients in the placebo group received an identical volume of normal saline.Hemoglobin level was measured four hours before and after the surgeries. Postoperative blood loss and hemoglobinchange as well as transfusion rates and volumes were compared between the two groups.Results:Mean Percentage fall in hemoglobin after surgery were 1.75±0.84 and 2.04±1.9 in the study and placebo groups,respectively (P=0.570). Hemoglobin loss was higher in the placebo group. Transfusion rates was lower in TA group(5.6%) compared to the placebo group (30%) (P=0.06). No significant difference in The Allowable Blood Loss during thesurgery was found between the two groups (P=0.894).Conclusion:Preoperative treatment with TA reduces postoperative blood loss and the need for blood transfusion duringtraumatic femoral fracture operation.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

does tranexamic acid reduce bleeding during femoral fracture operation?

background:proximal femoral shaft fractures are commonly associated with marked blood loss which can lead topostoperative acute anemia and some other complications.tranexamic acid (ta) is an antifibrinolytic medication that reduces intra-and postoperative blood loss and transfusionrequirements during some elective surgeries (1-3).the aim of this study is to evaluate the effect of intravenous tr...

full text

Use of tranexamic acid to reduce bleeding in burns surgery.

We describe, for the first time, the use of topical tranexamic acid as an adjunct to traditional methods in the control of bleeding in burns surgery. We illustrate our use with a case example and continue to discuss the reasons we believe it is a useful, effective and safe means of achieving haemostasis.

full text

Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial.

OBJECTIVE To compare the frequency of blood transfusion after surgery for fixation of inter-trochanteric fractures in patients given tranexamic acid versus placebo. METHODS The randomised control trial was conducted at the Aga khan university hospital from May 1 to October 31, 2014, and comprised patients diagnosed with Inter-trochanteric fracture based on X-ray imaging. The patients were ran...

full text

Does tranexamic acid decrease bleeding in patients undergoing cardiopulmonary bypass?

We reviewed the records of 66 patients who underwent cardiopulmonary bypass; half of these patients received the plasmin inhibitor, tranexamic acid. The demographics were not different between the group who received tranexamic acid and the group who did not (control group). There was no difference in the heparin or protamine requirements between the two groups. There was a significantly greater...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 5  issue 2

pages  103- 108

publication date 2017-03-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023